6 Meridian’s Supernus Pharmaceuticals SUPN Stock Holding History

6 Meridian’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$457K	Buy	15,667 +67	+0.4%	+$2.03K	0.03%	177
2021 Q3	$416K	Buy	15,600 +2,327	+18%	+$62.5K	0.03%	184
2021 Q2	$409K	Sell	13,273 -283	-2%	-$8.68K	0.03%	193
2021 Q1	$355K	Buy	13,556 +623	+5%	+$17.4K	0.03%	211
2020 Q4	$325K	Buy	12,933 +661	+5%	+$14.2K	0.03%	197
2020 Q3	$256K	Buy	+12,272	New	+$279K	0.03%	214

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

6 Meridian's SUPN Position: Q4 2021 in Review

6 Meridian increased its Supernus Pharmaceuticals (SUPN) stake by 0.43% in Q4 2021, buying an estimated $2.03K and bringing the position to 15,667 shares worth $457K. The position accounts for 0.03% of the portfolio, ranked #177.

6 Meridian first reported a position in SUPN in Q3 2020 and has held it in 6 quarters since. 235 funds tracked by Wall St. Rank hold SUPN as of Q4 2021.

6 Meridian held 15,667 shares of Supernus Pharmaceuticals worth $457K as of Q4 2021.
6 Meridian bought 67 Supernus Pharmaceuticals shares in Q4 2021, an estimated $2.03K.
Supernus Pharmaceuticals made up 0.03% of 6 Meridian's portfolio in Q4 2021, its #177 holding.
6 Meridian first reported a position in Supernus Pharmaceuticals in Q3 2020 and has held it in 6 quarters since.
235 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2021.

Based on 6 Meridian's 13F filing for Q4 2021, filed 1 Feb 2022.